Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/ lymphoproliferation (MRL/lpr) mice

Clinical and Experimental Immunology

Volumn 160, Issue 2, 2010, Pages 275-282

  Molano, I ^a   Mathenia, J ^b   Ruiz, P ^c   Gilkeson, G S ^a,b   Zhang, X K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Fli 1 transcription factor; Hematopoietic cells; Lupus

Indexed keywords

AUTOANTIBODY; TRANSCRIPTION FACTOR FLI 1;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CONTROLLED STUDY; HEMATOPOIETIC CELL; INFLAMMATORY INFILTRATE; KIDNEY DISEASE; KIDNEY NECROSIS; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; BONE MARROW TRANSPLANTATION; CELL LINEAGE; DISEASE PROGRESSION; FEMALE; HEMATOPOIETIC STEM CELLS; HETEROZYGOTE; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED MRL LPR; PROTO-ONCOGENE PROTEIN C-FLI-1; RADIATION CHIMERA; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 77950667082     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04080.x     Document Type: Article

References (25)

1. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994 330 : 1871 1879.
2. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003 56 : 481 490.
3. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious disease risk factors for the development of systemic lupus erythematosus. Arthritis Rheum 1998 41 : 1714 1724.
4. Watson DK, Smyth FE, Thompson DM et al. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ 1992 3 : 705 713.
5. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev 1991 5 : 908 918.
6. Georgiou P, Maroulakou IG, Green JE et al. Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome. Int J Oncol 1996 9 : 9 18.
7. Zhang L, Eddy A, Teng YT et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol 1995 15 : 6961 6970.
8. Spyropoulos DD, Pharr PN, Lavenburg KR et al. Hemorrhage, impaired hemotopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 2000 20 : 5643 5652.
9. Hart A, Melet F, Grossfeld P et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000 13 : 167 177.
10. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985 37 : 269 390.
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992 356 : 314 317.
12. Watson ML, Rao JK, Gilkeson GS et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992 176 : 1645 1656.
13. Zhang XK, Gallant S, Molano I et al. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol 2004 173 : 6481 6489.
14. Ikehara S, Kawamura M, Takao F et al. Organ-specific and systemic autoimmune disease originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990 87 : 8341 8344.
15. Li HS, Ligons DL, Rose NR, Guler ML. Genetic difference in bone marrow-derived lymphoid lineages control susceptibility to experimental autoimmune myocarditis. J Immunol 2008 180 : 7480 7484.
16. Sekine H, Reilly CM, Molano I et al. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL.lpr mice. J Immunol 2001 166 : 6444 6451.
17. Bradshaw S, Zheng W-J, Tsoib L-C, Gilkeson G, Zhang XK. A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clin Immunol 2008 129 : 19 30.
18. Zhang XK, Moussa O, LaRue A et al. The transcription factor Fli-1 modulates marginal zone and follicular B cell development. J Immunol 2008 181 : 1644 1654.
19. Li Y, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002 195 : 181 188.
20. Wellmann U, Wergner A, Winkler TH. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur J Immunol 2001 31 : 2800 2810.
21. Grimaldi CM, Michael DJ, Diamond B. Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001 167 : 1886 1890.
22. Rupprecht HD, Hoffer G, de Heer E, Sterzel RB, Faller G, Schoecklmann HO. Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation. Kidney Int 1997 51 : 694 702.
23. Carl M, Akagi Y, Weidner S, Isaka Y, Imai E, Rupprecht HD. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis. Kidney Int 2003 63 : 1302 1312.
24. Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene 1997 14 : 213 221.
25. Green RS, Stone EL, Tenno M, Lehton E, Farquhar MG, Marth JD. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogesis. Immunity 2007 27 : 308 320.